- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules
Nanomix Incorporated, a leading nanotechnology company commercializing nanoelectronic detection devices for industrial and biomedical applications, announced today the issuance of a U.S. patent for its nanostructured detection platform known as Sensation.
The patent includes broad claims related to nanostructured detection devices. These devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules. The devices have extremely low power requirements and are scalable for mass production in a variety of product applications.
"We are pleased with our emerging patent portfolio related to nanoelectronic detection, which supports our primary business focus," said David Macdonald, President and CEO of Nanomix. "These advancements open up a wide range of applications and commercial opportunities. As the first company to bring a nanoelectronic product to market, we are excited to be at the leading edge of this promising industry. In addition to our own products, we are currently pursuing a number of collaborations for the commercial deployment of Sensation technology."
This patent (US Patent No. 6,894,359, issued May 17, 2005) is the first to be issued in Nanomix' growing portfolio of pending patent applications for the Sensation detection platform and its industrial and biomedical uses. This follows the issuance of three previous patents related to Nanomix' hydrogen storage technology.
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistry and silicon. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanotechnology - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Leti Scientists Participating in Sessions on Med Tech, Automotive Technologies, MEMS, Si-photonics and Lithography at SEMICON Europa: Teams also Will Demonstrate Technology Advances in Telecom, Data Fusion, Energy, Silicon Photonics and 3D Integration October 18th, 2016
Nanowires as sensors in new type of atomic force microscope October 17th, 2016
Nanoscale engineering transforms particles into 'LEGO-like' building blocks October 12th, 2016
Metamaterial uses light to control its motion October 10th, 2016
Nanosciences: Genes on the rack October 21st, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
For first time, carbon nanotube transistors outperform silicon September 8th, 2016